CPAP
Devicepatients will receive CPAP therapy with Auto-CPAP
NCT Number: NCT02737215
Background. Atrial fibrillation is one of the most common complications in the postoperative period of coronary artery bypass grafting (CABG) surgery and usually associated with increased length of hospital stay and higher hospital costs. Among the main mechanisms involved, excessive sympathetic activation, oxidative stress and inflammation are fundamental elements in the pathophysiology of obstructive sleep apnea. Objectives. To evaluate the effects of continuous positive airway pressure (CPAP) in reduction of atrial fibrillation after CABG in patients with obstructive sleep apnea. Methodological procedures: A multicenter randomized controlled study to compare the incidence of atrial fibrillation between the intervention group and the control group, both monitored seven days with Holter.
Looking for future studies?
Notify Me30 year–75 year
All sexes
Interventional
Not applicable
Instituto de Medicina Integral Prof Fernando Figueira - Imip, Recife, Pernambuco, Brazil
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
patients will receive CPAP therapy with Auto-CPAP
Time frame: first 7 days after CABG
will be verified by holter monitoring
Rodrigo Pinto Pedrosa
Other
Prevention of Atrial Fibrillation After Coronary Artery Bypass Grafting in Patients With Obstructive Sleep Apnea: a Multicenter Study
Acronym: PAFOS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01058551
Apnea, Arrhythmias, Cardiac
Kingston, Ontario, Canada
View Trial DetailsNCT05990010
Apnea, Arrhythmias, Cardiac
Irbid, Ramtha, Jordan
View Trial DetailsNCT02332096
Apnea, Arrhythmias, Cardiac
Boston, Massachusetts, United States
View Trial DetailsNCT04814420
Apnea, Arrhythmias, Cardiac
New Orleans, Louisiana, United States
View Trial Details